AT2 receptor: Its role in obesity associated hypertension
Journal Title: International Journal of Clinical Pharmacology & Toxicology(IJCPT) - Year 2012, Vol 1, Issue 2
Abstract
The renin-angiotensin system (RAS) is a hormonal cascade that acts together to regulate blood pressure. Angiotensin II (Ang II) is the major octapeptide of RAS and mediates its cellular and physiological actions by acting on AT1 and AT2 receptor. Most of the cellular and physiological actions of Ang II such as cellular growth and proliferation, vasoconstriction, antinatriuresis and increase in blood pressure are mediated via AT1 receptor. The functions associated with the AT2 receptors are less studied, in part, due to its lower expression in adult tissues. However, AT2 receptor has been suggested as functional antagonist of AT1 receptors and thereby opposes the actions of Ang II mediated via AT1 receptor. Thus, the activation of AT2 receptors has been shown to cause vasodilatation, natriuresis and decrease in blood pressure. After the discovery of the AT2 receptor in various parts of the kidney, including in proximal tubules, there has been an interest in establishing a link between the renal AT2receptor, renal Na-excretion and blood pressure regulation. Earlier, we have reported that activation of renal AT2 receptors increases urinary Na excretion in obese Zucker rats, in part via inhibiting Na+/K+ - ATPase (NKA) activity and stimulating nitric oxide/cGMP pathway in the proximal tubules. An impaired pressure natriuresis and increased AT receptor function is believed to be the cause of hypertension in obese Zucker rats and other animal models of obesity. In this review, we are focussing on the role of renin angiotensin system especially AT2 receptors in obesity associated hypertension.
Authors and Affiliations
Tahir Hussain
Keywords
Related Articles
- EP ID EP201629
- DOI 10.19070/2167-910X-120003
- Views 63
- Downloads 0
Evaluation of the Cytotoxic Effects of Combined Application of Methotrexate and Statins on Green Monkey Kidney Cells
Lipid disorders that lead to cardiovascular diseases are also common with oncology patients. Therefore, this group of patients is exposed to the risk of interaction between the cytostatic drugs applied and statins. Metho...
PPAR α/γ Agonist in Management of Diabetic Dyslipidemia: A Review
Cardiovascular diseases are major contributors of mortality and morbidity in patients with type 2 diabetes mellitus (T2DM), while dyslipidemia and hyperglycemia are key modifiable risk factors to prevent coronary artery...
Deterioration of Brain Cell Function Induced by Dapoxetine Administration in Male Rats
Background and Aim of Work: Dapoxetine is a Selective Serotonin Reuptake Inhibitor (SSRI) decided for the remedy of premature ejaculation (PE) in adult men. The objective of this research was to determine the influence o...
Current Pharmacological and Non-Pharmacological Treatments of Panic Disorder/Agoraphobia
Anxiety disorders represent the most prevalent psychiatric disorders, however, many patients who might benefit from treatment are not diagnosed or treated. This may partly be due to lack of awareness of the anxiety disor...
Inhibitory Effect of Vernonia amygdalina on Dimethylnitrosamine (DMN)-induced Liver Fibrosis in Rats
In this study, the protective effect of Vernonia amygdalina ethanolic leaf extract against hepatic fibrosis induced by repeated intermittent administration of Dimethylnitrosamine (DMN) was investigated in rats. A total o...